Screening for serum biomarkers in patients with chronic hepatitis B with hepatitis B surface antigen seroclearance, following pegylated interferon alpha therapy

Publisher： Spandidos Publications

E-ISSN： 1791-3004|11|1|427-433

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.11, Iss.1, 2015-01, pp. : 427-433

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interleukin-28B genotypes determine response to pegylated-interferon plus ribavirin therapy in patients with hepatitis C virus infection

By                    

Molecular Medicine Reports, Vol. 5, Iss. 2, 2012-01 ,pp. : 525-528

Spandidos Publications

Access to resources Recommend Favorite

MHC class I-related chain B gene polymorphism is associated with virological response to pegylated interferon plus ribavirin therapy in patients with chronic hepatitis C infection

By  

Biomedical Reports, Vol. 3, Iss. 2, 2015-01 ,pp. : 247-253

Science Publishers

Access to resources Recommend Favorite

Effects of antiviral therapy on the cellular immune response in patients with chronic hepatitis B

By  

Molecular Medicine Reports, Vol. 11, Iss. 2, 2015-01 ,pp. : 1284-1291

Spandidos Publications

Access to resources Recommend Favorite

Association between polymorphisms of the E-selectin gene, hepatitis B virus DNA copies and preS1 antigen in patients with chronic hepatitis B infection

By              

Molecular Medicine Reports, Vol. 6, Iss. 5, 2012-01 ,pp. : 1069-1074

Spandidos Publications

Access to resources Recommend Favorite

Modulation of hepatitis B surface antigen secretion by annexin II expressed in hepatitis B virusproducing hepatoma cells

By  

Molecular Medicine Reports, Vol. 10, Iss. 6, 2014-01 ,pp. : 3113-3117

Spandidos Publications

Access to resources Recommend Favorite